Clinical trials to determine treatment efficiency for lower-limb problems often involve qualitative assessment of subject pain and function level. As results can notoriously vary based on patient mood or the user, often more patients must participate than would otherwise be necessary, to identify the signal amongst the noise.
GaitSmart offers a novel solution by enabling objective quantification of gait in a portable affordable manner - opening up a world of access to quantitative patient measurements in clinical trials involving mobility.
Overall patient mobility greatly improved - crucially reducing patient reliance on walking aids.
As part of an exciting collaboration with APPROACH EU, correlation was recently demonstrated between GaitSmart parameters and stage of osteoarthritis - the implications of this are huge!
Read about the study HERE.
A patient experiencing pain will not walk as well, making changes in gait the perfect surrogate marker.
We have databases drawn from ten years of experience that show gait changes correlate with pain and function.
As well as quantifying gait for staging and monitoring, we also offer personalised rehabilitation. Read about our clinical trial with Norfolk and Norwich Hospital providing rehabilitation HERE
GaitSmart's digital technology measures the movement of the calf, thigh, knee and hips in three dimensions with extraordinary accuracy (±0.1 deg) - validated at the National Physics Laboratory. Improvement of a few degrees can be detected across 17 different parameters. GaitSmart is also a CE Marked Class 1m Medical device.
The full study with NPL can be found HERE.